Roivant Sciences ROIV Business Segments — Gain (Loss) on Investments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Roivant Sciences in its filing.
Tagged under the XBRL concept us-gaap:GainLossOnInvestments.
The official record: Roivant Sciences’s 10-Q, filed February 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Roivant Sciences's business segments — gain (loss) on investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Roivant Sciences's business segments — gain (loss) on investments?
- Roivant Sciences (ROIV) reported business segments — gain (loss) on investments of $21.59M in Q4 2025.
- How has Roivant Sciences's business segments — gain (loss) on investments changed year-over-year?
- Roivant Sciences's business segments — gain (loss) on investments increased by 201.3% year-over-year, from -$21.31M to $21.59M.
- What does business segments — gain (loss) on investments mean?
- This reflects the change in the market value of financial investments held by the segment, including realized and unrealized gains or losses. It measures the performance of the segment's treasury or strategic investment portfolio.